Are applicants for a driver's license asked questions about diabetes?
Yes. The driver's license application (first-time and renewal) asks an applicant whether he or she has diabetes. If an applicant answers yes to this question, he or she is required to have a physician complete a medical report form. N.M. Stat. Ann. 66-5-14(A) (2013) (generally authorizing the licensing agency to examine driver's license applicants for "anyphysical and mental examination as [it] finds necessary to determine the applicant's fitness to operate a motor vehicle or motorcycle safely upon the highways").
What other ways does the state have to find out about people who may not be able to drive safely because of a medical condition?
The state accepts reports of potentially unsafe drivers from police officers, physicians, family members, friends, other citizens, and hospitals. The licensing agency accepts anonymous reports and does not investigate reports before a driver is contacted for medical review. Drivers also may be required to have medical evaluations if they are involved in a given number of at-fault crashes within a given time period, if they are involved in at-fault crashes resulting in a fatality, or if they have impairments which are observed by licensing agency personnel during the licensing process. N.M. Stat. Ann. 66-5-30(A)(2), (B) (2013) (authorizing the licensing agency to suspend or revoke a driver's license because of his or her involvement in an accident and providing for reinstatement after reexamination); N.M. Stat. Ann. 66-5-31 (2013) (authorizing the licensing agency to compel a medical evaluation if it has good cause to believe that a driver is incompetent or otherwise unqualified to be licensed).
What is the process for medical evaluations of drivers?
Individuals with diabetes must undergo medical evaluations when applying for driver's licenses for the first time and at all subsequent renewals. A Medical Report Form (MVD10124) is sent to an individual, which must be completed by his or her physician within 30 days. The Medical Report Form asks the physician whether the patient has diabetes, hypoglycemia, loss of consciousness, or other conditions. N.M. Motor Vehicle Division, "Medical Report," Form MVD10124 (Rev. 06/2013). If so, the physician must describe the condition and its treatment (including any medications that the patient is taking); to state whether the condition is currently controlled; and to provide test results that may be relevant. The physician also is asked to give an opinion on the following 1) whether, medically speaking, the individual is capable of safe and competent driving; 2) whether the individual suffers from any abnormal personality traits; 3) whether there should be any appropriate licensing restrictions; and 4) how often follow up any medical evaluations should be required. N.M. Motor Vehicle Division, "Medical Report," Form MVD10124 (Rev. 06/2013). Medical Report Forms are returned to the licensing agency for review and a licensing decision.
Are physicians required by law to report drivers who have medical conditions that could affect their ability to drive safely?
There is no statutory authority requiring physicians to report drivers with medical conditions that could affect their ability to drive safely to a central state agency.
Are physicians who report drivers with medical conditions immune from legal action by the patient?
There is no statutory authority providing immunity from civil or criminal liability for physicians who report or fail to report drivers with conditions that could affect their ability to drive safely to a central state agency.
Who makes decisions about whether drivers are medically qualified?
For individuals that do not take insulin or take insulin and have been under treatment for at least eight years, licensing agency personnel will issue a license so long as an individual's physician indicates on the medical evaluation form that he or she is medically fit to drive. Individuals that do not meet this condition, i.e., that have been taking insulin for less than eight years, are referred to the state's independent Health Standards Advisory Board. When diabetes cases are referred to the board, one membera general medical doctor, not an endocrinologistgenerally makes decisions, and the process generally takes four to eight weeks. The board may require additional on-the-road examinations or any other physical tests recommended by the Board. N.M. Stat. Ann. 66-5-6(B)-(C) (2013) (board may require road tests or other examinations). Although the Health Standards Advisory Board may advise licensing agency personnel with regard to licensing decisions, N.M. Stat. Ann. 66-5-6(B)-(C) (2013), ultimate authority over licensing decisions resides with the licensing agency itself. N.M. Stat. Ann. 66-5-24(A), -30(A)(1)-(11) (2013).
What are the circumstances under which a driver may be required to undergo a medical evaluation?
Upon five days' written notice, a driver may be required to undergo a medical evaluation if the licensing agency has good cause to believe that he or she is incompetent or otherwise unqualified to be licensed. N.M. Stat. Ann. 66-5-31 (2013). A driver may be required to undergo a medical evaluation if, upon review of his or her case, the Health Standards Advisory Board determines that such an evaluation is necessary to making a recommendation as to a licensing decision. N.M. Stat. Ann. 66-5-6(C) (2013). Drivers also may be required to have medical evaluations if they are involved in a given number of at-fault crashes within a given time period, if they are involved in at-fault crashes resulting in a fatality, or if they have impairments which are observed by licensing agency personnel during the licensing process. N.M. Stat. Ann. 66-5-30(A)(2), (B) (2013) (authorizing the licensing agency to suspend or revoke a driver's license because of his or her involvement in an accident and providing for reinstatement conditioned upon reexamination); N.M. Stat. Ann. 66-5-31 (2013) (authorizing the licensing agency to compel a medical evaluation if it has good cause to believe that a driver is incompetent or otherwise unqualified to be licensed).
Has the state adopted specific policies about whether people with diabetes are allowed to drive?
No. New Mexico has adopted no specific medical guidelines related to diabetes since most diabetes cases are decided on a case-by-case basis by the Health Standards Advisory Board.
What is the state's policy about episodes of altered consciousness or loss of consciousness that may be due to diabetes?
New Mexico has not adopted a policy about episodes of loss of consciousness but is working to develop such a policy. The state has adopted a policy regarding seizures, however, which requires that an individual who has had a seizure submit to the licensing agency a statement from a physician indicating that he or she has been seizure or episode-free for at least one year and that he or she either is not under medication or is taking medication without side effects before he or she will be licensed. N.M. Code R. 18.19.5.34(B) (2013). If an individual that has had a seizure has been issued a restricted license, the licensing agency may remove any restrictions early if the individual is able to produce a satisfactory physician's statement. N.M. Code R. 18.19.5.34(A) (2013).
Does the state allow for waivers of this policy, e.g., a waiver for a one-time episode of severe hypoglycemia that has mitigating factors (e.g., recent change in medication, illness, etc.) or that has been addressed with a physician?
No. There is no statutory authority providing for exceptions to New Mexico's policy regarding episodes of loss of consciousness and driver licensing. Again, if an individual that has had a seizure has been issued a restricted license, the licensing agency may remove any restrictions early if the individual is able to produce a satisfactory physician's statement, as described above. N.M. Code R. 18.19.5.34(A) (2013).
What is the process for appealing a decision of the state regarding a driver's license?
An individual may make a written request for a hearing in the county in which he or she resides, which must be received by the licensing agency within 20 days of the suspension notice. N.M. Stat. Ann. 66-5-30(B) (2013) (describing hearing process in detail). The licensing agency, in its discretion, may extend the 20-day request period. A hearing then is held so that an individual may provide proof as to his or her ability to operate a motor vehicle safely. Both the individual and the licensing agency may present evidence and testimony, and the individual may be required to undergo a driver examination. The licensing agency then will rescind, continue, modify, or extend the suspension. N.M. Stat. Ann. 66-5-30(B) (2013). Except in cases of mandatory suspension or revocation, decisions of the licensing agency also may be appealed to the district court. N.M. Stat. Ann. 66-5-36 (2013). For more information, see N.M. Motor Vehicle Division, "Hearing Requests," (Accessed 2013); N.M. Motor Vehicle Division, "Request for Hearing," Form MVD-10792 (Rev. 12/2008).
May an individual whose license is suspended or denied because of diabetes receive a probationary or restricted license?
No. However, the licensing agency may, whenever good cause appears, issue a license with restrictions, including the shortening of the licensure period, appropriate to ensure the safe operation of a motor vehicle by the licensee. N.M. Stat. Ann. 66-5-19(A) (2013); N.M. Code R. 18.19.5.32, 18.19.5.3(A) (2013) (providing for the issuance of restricted licenses, or licenses with shorter licensure periods).
Is an identification card available for non-drivers?
Yes, with proper identification, proof of residency, and payment of a fee. See N.M. Stat. Ann. 66-5-402 (2013) (describing identification and proof of residency requirements); N.M. Code R. 18.19.5.12(A) (2013) (same). An individual may not hold an identification card and a driver's license concurrently. N.M. Stat. Ann. 66-5-401(A), -402(A) (2013). An identification card is valid for a period of four years or, at the election of the holder, a period of eight years if he or she pays the applicable fee for an eight-year period. N.M. Stat. Ann. 66-5-403(A), (C) (2013). A $5.00 fee is required upon application for an identification card with a four-year term, and a $10.00 fee is required upon application for an identification card with an eight-year term. N.M. Stat. Ann. 66-5-408(A) (2013). Individuals 75 years of age or older may obtain identification cards free of charge. N.M. Stat. Ann. 66-5-408(A) (2013).
Resources
Driver licensing in New Mexico is administered by the Motor Vehicle Division of the State Taxation and Revenue Department.
Here is the original post:
New Mexico: American Diabetes Association
- This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it - The Times of India - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - ABC News - February 7th, 2025
- Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study - BMC Public Health - February 7th, 2025
- Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care - MultiVu - February 7th, 2025
- Q&A: Diabetes care for the aging population in the digital age - Medical Xpress - February 7th, 2025
- The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes - Nature.com - February 7th, 2025
- Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes - Managed Healthcare Executive - February 7th, 2025
- Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study - BMC Public Health - February 7th, 2025
- Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India - Nature.com - February 7th, 2025
- Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes - Nature.com - February 7th, 2025
- Sugary Drinks Fuel Millions of Diabetes and CVD Cases - Medscape - February 7th, 2025
- 1 in 5 UK adults estimated to have diabetes in new record high - Euronews - February 7th, 2025
- New, increasingly widely used diabetes medication may have additional health benefits for older adults - Medical Xpress - February 7th, 2025
- Patients using diabetes apps can miss critical alerts. Heres how to make sure youre getting them - Canon City Daily Record - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - News-Press Now - February 7th, 2025
- Does wearing a continuous glucose monitor help people without diabetes? We asked experts. - Popular Science - February 7th, 2025
- What is prediabetes and what can you do to stop it? - The Independent - February 7th, 2025
- Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet - India.com - February 7th, 2025
- The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts - EatingWell - February 7th, 2025
- 'Fix Broken Food System!' Government Urged as Study Says 1 in 5 Brits Affected by Diabetes - Men's Health UK - February 7th, 2025
- World Diabetes Day 2024 - World Health Organization (WHO) - December 6th, 2024
- The WHO Global Diabetes Compact - December 6th, 2024
- Diabetes - World Health Organization (WHO) - December 6th, 2024
- Kumamoto University researchers discover groundbreaking antidiabetic compound - EurekAlert - December 6th, 2024
- Med's David Kaelber comments on GLP-1 agonists, which provide benefits like managing diabetes and weight loss - The Daily | Case Western Reserve... - December 6th, 2024
- Jordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes Screening - Verywell Health - December 6th, 2024
- There's A Tasty Food That May Reduce Your Risk Of Developing Type 2 Diabetes, Study Shows - HuffPost - December 6th, 2024
- Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression - Medpage Today - December 6th, 2024
- GLP-1 Medications Associated with Reduced Likelihood of Dementia Compared to Other Diabetic Meds - Epic Research - December 6th, 2024
- Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News - December 6th, 2024
- Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal - December 6th, 2024
- New Study Teases Out Chocolate and Diabetes Connection - Medpage Today - December 6th, 2024
- Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com - December 6th, 2024
- Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN - December 6th, 2024
- Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |... - December 6th, 2024
- I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN - December 6th, 2024
- Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio - December 6th, 2024
- This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV - December 6th, 2024
- New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily - December 6th, 2024
- Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good - December 6th, 2024
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024
- Early vs Late Fast Window: Is One More Effective? - Medscape - September 13th, 2024
- Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU - September 13th, 2024
- Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek - September 13th, 2024
- Beds and Herts patients to be re-tested in diabetes results error - BBC.com - September 13th, 2024
- This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times - September 13th, 2024
- Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health - September 13th, 2024
- Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian - September 13th, 2024
- Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal - September 13th, 2024
- Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio - September 13th, 2024
- Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News - September 13th, 2024
- Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation - September 13th, 2024
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire - September 13th, 2024
- Dining with Diabetes workshops offered - The Courier-Express - September 13th, 2024
- Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net - September 13th, 2024
- The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The... - September 13th, 2024
- Artificial pancreas shows promise in people with type 1 diabetes on kidney dialysis - MSN - September 13th, 2024
- How an Indian executive battled flesh-eating disease and diabetes, and won - South China Morning Post - September 13th, 2024
- India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - PR Newswire - September 13th, 2024
- Why this diabetes drug may be the answer to NASA search for radiation protection - Texas Public Radio - September 13th, 2024
- The National Association of Chain Drug Stores and the American Diabetes Association Promote Nutrition Security and its Role in Preventing and Managing... - September 13th, 2024